In 1998 we reported that an L-peptide derived from H1 of c-Myc (Int-H1-S6A,F8A), linked to an internalization sequence from the third α-helix of Antennapedia, was endowed with an antiproliferative and proapoptotic activity toward a human mammary cancer cell line: The activity apparently depends upon the presence of the Myc motif. In the present work we have added new dimensions to our original findings. It is known that short retro-inverso (RI-) peptides can assume a 3D conformation very close to their corresponding L-forms and can be recognized by the same monoclonal antibody. We synthesized a RI-peptide form of our original L-peptide: It was much more resistant to serum peptidases than the original molecule (a half life of days rather than hours); in addition, the RI-form of the original Antennapedia internalization sequence was perfectly capable of carrying a D-peptide into human cells. We have studied three different potentially active peptides. L-peptides: Int-H1wt, Int-H1-S6A,F8A. Dpeptides: RI-Int-H1-S6A,F8A. We have also studied three presumed control peptides: Int and RI-Int (no H1 motif), H1-S6A,F8A (no internalization sequence). Both 'active' and 'control' peptides have essentially confirmed our expectations, however, in cells treated with the higher concentration (10 µM) of the control peptide RI-Int, non-Myc related side effects could be detected. In order to investigate whether the antiproliferative activities displayed by some of our molecules were indeed related to an interference with the role of c-Myc (and molecules of the family), we chose an iso-amphipathic modified peptide of the H1 motif, with a proximity coefficient >50% and where the major change was at position 7 (F→A). From a family of 73 H1 motifs belonging to (H1-Loop-H2) human sequences, the smallest evolutionary distance from our reference peptide was observed for the H1 of N-Myc, L-Myc, cMyc, H1-S6A,F8A of c-Myc, and Max, in that order. Our reference peptide was therefore appropriate as a check of whether we were indeed observing activities related to Myc functions. Both Int-H1isoamph and the corresponding RI-Int-H1isoamph peptide were synthesized and studied. In terms of biological targets, we added to the human mammary cancer line of our previous work (MCF-7 cells) a colon cancer line (HCT-116 cells) and also a system of normal cells: human peripheral blood lymphocytes (PBLs) stimulated with phytohemoagglutinin (PHA). Peptides carrying an iso-amphipathic-modified H1 sequence were always very clearly (3-10 times) less active than the corresponding peptides carrying a conserved "H1 of Myc" motif. This finding was noted in five independent situations (all the cellular
third α-helix of the homeobox protein Antennapedia) (13) . H1-S6A,F8A was fused at the carboxyterminus of the Int peptide (14) .
L-peptides are degraded by peptidases at a relatively rapid rate. We wanted more stable molecules capable of maintaining the same type of biological activity. We have tried with the synthesis of RIpeptides. In RI-peptides (peptides with the inverted sequence and made of D-amino acids) the topological position of the side chains of the aa is identical to the position of the side chains in the original L-peptide. This finding is particularly relevant for α-helices, in which the oxygen and the nitrogen atoms of the peptidic bond CO-NH are engaged in the formation of the α-helix and in the case of interactions among different α-helix motifs, as in the formation of a four-α-helix bundle. The structural similarity of L-peptides and their retro-inverso counterparts has been clearly shown by monoclonal antibodies induced against an L-peptide, which displayed a similar binding affinity for the corresponding retro-inverso peptide (15) .
In this work, we investigated our RI-peptide RI-Int-H1-S6A,F8A, and several related RI-and Lpeptides, in two human cancer lines where c-Myc is overexpressed: MCF-7 from a mammary cancer (16) , HCT-116 from a colon cancer (O'Connor P.M., personal communication), and in a normal cell type, peripheral human blood lymphocytes (PBLs) stimulated with phytohemoagglutinin (PHA). PHAstimulated PBLs are known to be c-Myc-dependent for their entering into S phase (17) .
MATERIALS AND METHODS

Peptides synthesis, purification and characterization
List of the peptides studied
L-peptides:
Int NH2-RQIKIWFQNRRMKWKK-COOH H1-S6A,F8A
NH2-NELKRAFAALRDQI-COOH Int-H1-S6A,F8A
NH2-RQIKIWFQNRRMKWKKNELKRAFAALRDQI-COOH Int-H1wt NH2-RQIKIWFQNRRMKWKKNELKRSFFALRDQI-COOH Int-H1isoamph NH2-RQIKIWFQNRRMKWKKQDARKLALFIRENA-COOH
RI-peptides:
RI-Int CH3CONH-KKWKMRRNQFWIKIQR-CONH2 RI-Int-H1-S6A,F8A
CH3CONH-IQDRLAAFARKLENKKWKMRRNQFWIKIQR-CONH2 RI-Int-H1isoamph
CH3CONH ANERIFLALKRADQKKWKMRRNQFWIKIQR-CONH2
The peptides were synthesized manually by using the standard method of solid-phase peptide synthesis, which follows the 9-fluorenylmethoxycarbonyl (Fmoc) strategy with minor modifications. Briefly, 65 µmol of deprotected RINK AM resin (Novabiochem) were treated for 40 min at 40°C with a coupling reaction mixture containing five equivalents (eq.) of the appropriate Fmoc-amino acid (Novabiochem), 4.5 eq. of o-(7-azabenzotriazol-1-yl)-1,1,3,3tetramethyluroniumhexafluorophosphate (PRIMM), five eq. of N,N-diisopropilethylamine (Fluka Chemie AG, Buchs, Switzeland), 7.5 eq. of sim-collidina (Fluka) at 0.2 M amino acid final concentration in anhydrous N-methylpyrrolidone (Fluka).
All the synthesized compounds were purified by reverse-phase high-performance chromatography (RP-HPLC), and the molecular weights were finally confirmed by electrospray mass spectrometry (ES-MS).
The purification of individual compounds was obtained on a Shimadzu LC-9A preparative HPLC, equipped with a Waters C18 µBondapack column (19 × 300).
Mass spectra of each compound were acquired by using a single quadrupole HP Engine 5989-A equipped with an electrospray ion source (ES-MS) and set in the positive-ion mode and confirmed with a Kompact MALDI 4 TOF spectrometer (Kratos Analytical, Manchester, U.K.).
The RI-derivative RI-Int-H1-S6A,F8A and the other two RI-peptides were prepared with amino acids in D-configuration and inversion of the sequence COOH to NH2 terminus (see above sequence schemes); the end-groups were protected with amid and acetyl groups in order to obtain close complementarity and full topological relationship to the parent peptide.
Half-life of L-Int-H1-S6A,F8A and RI-Int-H1-S6A,F8A
Using an HP 1090 HPLC equipped with a WATERS C18 µBondapack column (3.9 x 300 mm), we studied the half-life of the two peptides in medium RPMI 1640 supplemented with 5% FBS (different batches of fetal bovine serum by Euroclone). The solvent program was a gradient starting with 100% solvent A for 5 min., which increased linearly to 100% solvent B in 30 min. Solvent A was 0.1% trifluoroacetic acid (TFA) in water and solvent B was 0.1% TFA in acetonitrile. The diode array detector was set at 220 nm during the analyses.
We have estimated the residual concentrations of the peptides (in respect to the ones at time zero) at different times, and in four different experiments. We extrapolated the kinetic constant (k) of the degradation rate of the two peptides, while considering the degradation reaction a first-order reaction:
-dc/dt = kc [1] and by integration ln(c t /c o ) = -kt [2] where t is in hours.
Investigation of peptide internalization with rhodaminated peptides
Int-H1-S6A,F8A and H1-S6A,F8A peptides were rhodaminated (conjugation of a rhodamine B group at the NH 2 -terminal region) and purified (>90%) by HPLC by the company TIB MOLBIOL (Genova, Italy). The terminal carboxyl group was amidated.
MCF-7 cells were cultured in RPMI 1640 supplemented with 10% FCS. Rhodaminated Int-H1-S6A,F8A and H1-S6A,F8A (10 µM each) were added to the culture medium in the presence of peptidase inhibitors (Aprotinin 1µg/ml, Leupeptin 10 µg/ml). MCF-7 cells were grown on an appropriate cover slide. 50 µl of complete medium containing our fluorescent peptide (10 µM) was added over the intact cells. This cover slide was reverted and placed over a slide. The margins of the cover slides were sealed with a tiny amount of nail polish.
After 4 h of incubation at 37 °C, the cells were examined with a Zeiss Fluorescence Microscope by using a 100-W (HBO 100W/2 OSRAM) lamp, an excitation cut-off at 546 nm, an emission cut-on at 580 nm, and a X40 Zeiss Neofluar objective.
Internalization of the two Rd-molecules in intact, not permeabilized, peripheral lymphocytes stimulated with PHA was assessed by flow cytometric measurements. Briefly, lymphocytes were incubated for different times at 4°C or 37°C, with 10 µM of rhodaminated peptides, and were measured on a FACSCalibur (Becton Dickinson, San Jose, Calif.) equipped with a 488-nm laser for proper Rd excitation and suitable filters for Rd emission. Exclusion of dead cells and debris was performed on bivariate Forward Scatter/Side Scatter plots, and fluorescence of live cells was measured on a linear scale and evaluated in terms of percentage of positive cells as well as by peak fluorescence value (peak channel).
Growth curves of MCF-7 cells and HCT-116 cells
MCF-7 cells (human breast carcinoma) were obtained from American Type Culture Collection (Manassas, Va.), maintained in RPMI 1640 supplemented with 10% fetal calf serum (Life Technologies, Inc.) and 10 mM glutamine, and cultured in 5% CO 2 at 37°C. MCF-7 cells (2 × 10 4 /well) from an exponentially growing culture were plated in triplicate in 3.5 cm/diameter tissue culture dishes 24 h before the first treatment. Cells were exposed to different concentrations of peptides for a total of three treatments at days 1, 4, and 7. At each treatment, the medium was substituted with fresh medium. Cells were detached from independent dishes by using our trypsin/EDTA buffer (10-min incubation at 25°C) and counted daily. Growth curves of treated and control cells were obtained by means of a hemocytometer count and the trypan blue dye exclusion test. Each experimental point was determined in duplicate in parallel with three replicate controls: These experiments were repeated at least twice.
HCT-116 cells (human colon carcinoma cells) were a gift of Dr P. M. O'Connor (Agouron Pharmaceuticals, Inc., San Diego, Calif.) and maintained in RPMI 1640 supplemented with 5% fetal bovine serum (Euroclone) and 10 mM glutamine, and cultured in 5% CO 2 at 37°C. 2.7 × 10 4 HCT-116 cells from an exponentially growing culture were plated in duplicate, in 3.5 cm/diameter tissue culture dishes, 24 h before the first treatment. Cells were maintained for nine days in RPMI 1640 serum-free medium, and were exposed to different concentrations of L-peptides for a total of three treatments at days 1, 4, and 7. At each treatment the medium was substituted with fresh medium. Growth curves of treated and control cells were obtained by means of a hemocytometer count and the tripan blue dye exclusion test. Cells were counted daily. Duplicate experiments were repeated at least twice.
PBLs proliferation assay
Human PBLs were isolated from heparinized blood of healthy volunteers by Ficoll-Hypaque density gradient centrifugation and were re-suspended at a density of 1 × 10 6 cells/ml in complete medium [RPMI 1640 supplemented with 5% heat-inactivated fetal calf serum, 2 mM L-glutamine, penicillin (50 units/ml) and streptomycin (100 mg/ml)] and were cultured in 5% CO 2 at 37°C in the presence of the mitogen Phytohemagglutinin (PHA), (10 µg/ml). The proliferative response to mitogenic stimulation was determined by [ 3 H]-thymidine incorporation, during the last 18 h of 90-h experiments.
A total of 2 × 10 5 cells were cultured in 96-multiwell round bottom microtiter plates, in triplicate, in 200-µl complete medium/well, in the presence or the absence of 10 µg/ml of PHA. PHA was present during the last 54 h of treatment. DNAs were collected on glass wool filters by using a cell harvester. The filters were transferred to vials with scintillation fluid. [ 3 H]-thymidine incorporation was measured in a liquid scintillation counter. In PBLs not stimulated with PHA we regularly measured a background of counts corresponding to ~15% of the counts observed in PHA stimulated PBLs. This baseline of counts was systematically subtracted. In our experimental conditions, the average amount of cpm measured in PHA stimulated PBLs was 10,767 ± 1,126 (SE).
RT-PCR analysis
As indicated in the scheme illustrated above, PHA stimulation of peripheral blood lymphocytes was preceded and followed (12 h before and after PHA stimulation) by treatments with our L-or RIpeptides. RNA extraction took place 12 h after the last and third treatment and 24 h after PHA stimulation.
Total cellular RNA was isolated from treated and untreated PBLs by a Guanidine Isothiocyanate method as described by Chomczynski and Sacchi, with some modifications (18) . Cells were harvested from plates and immediately centrifuged at 1,500 RPM for 5 min at 4°C; pellets were washed twice in sterile PBS (Phosphate Buffered Saline: 137 mM NaCl, 2.7 mM KCl, 4.3 mM Na 2 HPO 4 , 1.4 mM KH 2 PO 4 , pH 7.4) and lysed in an appropriate amount of GTC Buffer, (GTC Buffer: 4 M Guanidinium Isothiocyanate; 25 mM Na-Citrate pH 7; 0.5% Sarcosyl; 100 mM β-mercaptoethanol). An equal volume of Acid Phenol:Chloroform:Isoamil Alcohol (Volume Ratio 25:24:1) was added to the lysates. The aqueous phases were added with 300 mM Na-Acetate and two volumes of Absolute Ethanol, and let to sediment at -20°C for 2 h. Phenol extraction and alcohol precipitation were repeated twice, and the final pellets were re-suspended in 50 µl of DEPC-treated water (0.01% Diethylpyrocarbonate in bidistilled water).
RNA was quantified by absorbance at 260 nm, and purity was assessed by comparison with absorbance at 280 nm. Quantification was confirmed by fractionation on agarose-formaldehyde gels staining the ribosomal bands with ethidium bromide (0.5 µg/ml).
A measure of 2 µg of total RNA was reverse-transcribed by using oligo dT as primers by Mo-MLV Reverse Transcriptase (Promega) following the manufacturer's instructions, in a reaction volume of 20 µl; 2 µl of cDNA was amplified by PCR. The polymerase chain reaction was carried out in a 20-µl volume containing 0.5 µM each of oligodeoxynucleotide primers, 250 µM each of deoxynucleotide triphosphate, 2 mM magnesium chloride and 1 U of Taq polymerase (Promega).
The samples were processed in a 9700 Thermal Cycler (Perkin Elmer) through a different number of cycles, depending upon the gene considered, to avoid reaching an amplification plateau. At each cycle the following steps were performed: 60 sec at 94°C (denaturation); 45 sec at 59°C for ODC and p53, at 57°C for GAPDH (glyceraldehyde-3-phosphate dehydrogenase) (annealing); and 45 sec at 72°C (elongation). The amplification products (15 µl) were analyzed by electrophoresis on a 1.2 % agarose gel stained with ethidium bromide (.5 µg/ml). The numbers of cycles were 23 for GAPDH; 26 for ODC; 28 for p53.
The primers used for ODC (forward, 5'-GAG CAC ATC CCA AAG CAA AGT-3'; reverse, 5'-TCC AGA GTC TGA CGG AAA GTA-3') amplified a fragment of 364 bp (12, 13) ; the primers for p53 (forward, 5'-CTA CAA GCA GTC ACA GCA CAT-3'; reverse, 5'-CAC AAA CAC GCA CCT CAA AGC-3') amplified a fragment of 341 bp; the primers used for GAPDH (forward, 5'-GGT CAT CCC TGA GCT GAA CG-3'; reverse, 5'-TTC GTT GTC ATA CCA GGA AAT G-3') amplified a fragment of 295 bp.
To make our RT-PCR analysis semi-quantitative, all the procedures following c-DNA amplification have been kept as invariant as possible. We have always used the same gel electrophoresis apparatus (Wide-mini Sub cell GT Biorad) linked to the same power supply (Biorad Power Pack 3,000). Gels (80 ml of 1.2% agarose, 5-mm thickness) were always run in TAE buffer (0.04 M Tris-acetate, 1 mM EDTA, pH 8) and Ethidium Bromide (EB) 1.3 µM (0.5 µg/ml) was added directly to the agarose immediately before pouring it on the gel tray. Runs were carried out at a constant voltage (4 V/cm, for 30 min). Because EB migrates in the opposite direction of DNA, we run the gel for a short time to make sure that amplified c-DNA bands were in an area of the gel still covered by the intercalating agent. In this way, the fluorescence background was also substantially invariant.
The gels were photographed with a standard apparatus and an invariant geometry. We always used a Polaroid photographic apparatus (MP4 Land Camera), a Pos/Neg 55 Polaroid Land Film, and a Biorad UV Generator (emission: 312 nm) as light source. The stop diaphragm was set at f/8 and the exposure time, 15 sec. After being washed extensively with distilled water, the negatives were fixed with Na sulfite 2%, for 1 h, at room temperature. In these conditions, the intensity of band fluorescence and formation of silver grains are reasonably linearly proportional. Negatives were scanned by using a Hewlett Packard Scanjet 6200 C at a resolution of 300 dot per inch. Digital images were analyzed with a NIH Image software (ver. 6.1).
The rate of amplification of the three different c-DNA (GAPDH, ODC and p53) was investigated by examining the progressive increase in band intensity for increasing numbers of PCR amplification cycles. Cycle numbers for each gene was chosen in a linear zone of the amplification curve. The curves obtained for each c-DNA can be described by equations of this type: 
where:
[ The values of R 2 are rather high: More than 90% of the variation of y as f(x) is explained from the slope; concomitant SE values are correspondingly small. We can hope that, from parallel experiments repeated a sufficient number of times, it should be possible to extract average ratios above the unavoidable noise implicit in this experimental approach.
RESULTS
Features of our Int-H1isoamph and RI-Int-H1isoamph peptides
Before discussing our experimental results, we introduce a computer/databank analysis of our reference iso-amphipatic modified peptides.
To investigate whether the antiproliferative activity of our active L-and RI-peptides is indeed related to the presence of a c-Myc H1 motif in their sequence, we synthesized for both types of peptides a reference sequence in which an iso-amphipatic modified H1-S6A,F8A (or RI-H1-S6A,F8A) sequence was attached to an intact Int (or RI-Int) sequence, respectively. We wanted this sequence to be closer to the H1 motif of Myc than to most H1 motifs of known Helix-Loop-Helix (HLH) domains.
We chose an iso-amphipathic modified sequence in which non-polar side chain amino acids have been replaced by other amino acids within their own family, the acidic side chain Asp only with its homologous Glu or vice versa. We did the same for the uncharged polar side chain Asn and its homologous Gln, and finally for the basic side chains Lys and Arg, and also left invariant, for combinatorial reasons, the eleventh amino acid of the peptide (Arg).
With the help of the program SMART [Simple Modular Architecture Research Tool V3.1 (19)], we 'fished' a total of 73 different human HLH sequences. These sequences have been aligned with the help of a second program also available on-line (20) . The evolutionary distance of the 73 H1 motifs (14 aa) from our reference iso-amphipatic modified sequence QDARKLALFIRENA (non-polar residues underlined, basic residues in bold characters) was evaluated by using the Dayhoff 'log odds matrix' approach (21) . A default value of 8 is usually added to each gap penalty (to have the highest gap penalty between C and W brought to 0). From our analysis of the data, a 'Dayhoff Score' of 80 was roughly equivalent to zero proximity between two peptides, therefore 'Proximity (percentage)' was defined as: [100⋅('Dayhoff Score' of a given peptide -80)/('Dayhoff Score' of the reference peptide -80)]. To the list of 73 H1 14 aa motifs we added our H1-S6A,F8A of c-Myc and a non-iso-amphipatic modified sequence where the seven non-polar residues have been permutated with the polar ones: ALQALDRKREFIAN. We obtained the following ranking:
1 2 3 4 5 6 7 8 9 10 11 12 13 14
Considering the 76-elements set made of 73 H1 natural motifs + H1isoamph + H1-S6A,F8A + H1non-isoamph, the Myc/Max family is the closest one to our H1isoamph peptide. The H1 motifs of other partners of Max, such as Mad4, Mnt, Mad1, and Mxi1, are already less-closely related. A H1non-isoamph peptide would have been completely different, not only from H1isoamph but also from H1wt of c-Myc ("Dayhoff Score" = 81; "% Proximity" = 1) and from H1-S6A,F8A of c-Myc ("Dayhoff Score" = 85; "% Proximity" = 5). Our iso-amphipatic-modified peptide differs from H1 of c-Myc mainly at three important positions: 7, 3, and 14, where a Phe, a Leu, and a Ile, respectively, have been changed into three smaller Ala. These conserved residues are involved in the formation of the core of the four-helix bundle.
Half-life of peptides Int-H1-S6A,F8A and RI-Int-H1-S6A,F8A in different batches of 5% fetal bovine serum + RPMI 1640 culture medium
We have estimated the residual concentration of the two peptides (in respect to the initial concentration at time zero = 50 µM), dosing our peptides as indicated in the Materials and Methods section, at times 0, 3, 5, and 24 h, both for L-and RI-peptides. The results obtained are illustrated in Table 1 .
The capabilities (by the four different serum batches that we have tested) of degrading at 37°C the Lpeptide Int-H1-S6A,F8A and the corresponding RI-peptide RI-Int-H1-S6A,F8A showed a rather significant variability from batch to batch, of about four times. The most active serum would degrade Int-H1-S6A,F8A at an hourly rate of ~15%, and the least-active serum would degrade our L-peptide at a rate of ~3.7% per hour. The corresponding RI-peptide was always about 30-35 times more resistant to degradation.
The difference in stability of RI-peptides, in comparison with L-peptides is more than sufficient to explain their higher potency on a molar basis. For parallel experiments comparing active and inactive peptides, the same batch of serum was always used, preferring sera within a 5%-10% range of degradation rate per hour.
Peptide internalization
Internalization of the active peptide Int-H1-S6A,F8A and its counterpart H1-S6A,F8A, lacking the Int internalization sequence, was studied by using rhodaminated (Rd-) peptides at the amino terminal region. Internalization was studied in all three of our cellular models: 1) exponentially growing MCF-7 cells; 2) exponentially growing HCT-116 cells; 3) PBLs stimulated with PHA 18 hours in advance. The concentration of Rd-peptides was always 10 µM. At first sight, similar concentrations of Rd-Int-H1-S6A,F8A seem to be present in the peripheral cytoplasm and in the nucleus. In some cells, however, we observed a higher concentration of our fluorescent peptide in the perinuclear region and/or at the level of nucleoli. A truncated, fluoresceinlabeled, HIV-1 Tat protein basic domain (minimum length 11) was also capable of rapid internalization (22), probably with the same type of mechanism of the Antennapedia Int peptide. The short basic Tat sequence could reach the nucleus easily, and also in this case a nucleolar accumulation was reported. This nucleolar accumulation of basic peptides could be related to a non-sequence-specific binding with the abundance of rRNA present in nucleoli of cells in exponential growth.
Because the cover-slide has an area of ~5 cm 2 , 50 µl of medium plus fluorescent peptide form a chamber that is approximately 0.1 mm deep. For this depth of our chamber (0.1 mm), fluorescence intensity (in arbitrary units, four independent slides, approximately 100 MCF-7 cells examined in each slide containing approximately 1000 cells) was (average ± SE):
31.0 ± 0.9 outside the cells 153.4 ± 4.0 peripheral cytoplasm 172.6 ± 2.5 nuclear region 225.3 ± 3.3 perinuclear region/nucleoli (when more fluorescent than the surrounding).
The same type of results was obtained with HCT-116 cells (data not reported). In conclusion, probably as a consequence of low-affinity bindings, the concentration of our peptide inside the cells was five to six times higher than in the extracellular medium. Because in the microchamber the amount of total peptide was in large excess of the amount of bound peptide, the concentrations of free peptide outside and inside the cell (both cytoplasmic and nuclear compartments) could still be similar.
The behavior of PHA-stimulated PBLs, when incubated in complete medium plus 5% serum, with our two fluorescent peptides, is shown in Figure 2 . Stimulated PBLs were investigated after 15 min or 4 h incubation. Both eye inspection and examination of the numbers (fluorescence channel for the mode of the peak and percentage of cells present in the channel interval 60-780), suggest that the entry of Rd-H1-S6A,F8A (lacking the Int internalization peptide) inside PBLs is decisively poorer than the entry of Rd-Int-H1-S6A,F8A (23).
As already observed by Derossi et al. (13) entry into cells is not temperature-dependent and therefore not energy-dependent. The phenomenon is relatively rapid, because after 15 min of incubation at 37°C the process of Int-driven penetration seems to be about two-thirds completed. Superimposable results have been obtained in three independent experiments. According to our results, in all three cellular models the presence of the third α-helix of Antennapedia protein is necessary and sufficient for internalization.
Inhibition of growth by L-peptides in the breast cancer line MCF-7
The growth curves of control MCF-7 cells and cells treated with our L-peptides, are reported in Figure  3 (top graph). A rather regular exponential growth can be observed up to day eight. It can be described by the equation: {Log 10 (N t /N 0 ) = [(Log 10 2)/T]· t}. In Table 2 we give the slopes (K) of the different exponential growths, R 2 values of their regression lines, T (doubling time), and (T: % over controls).
MCF-7 cells were treated at days 1, 4, and 7 after cell seeding with 30-µM concentrations of the following L-peptides: Int, Int-H1-S6A,F8A, Int-H1wt, and Int-H1isoamph. Exhausted medium was changed at each treatment, and controls received only fresh medium. In our experimental conditions, during the phase of exponential growth (from day 1 to day 8, considering day 0 the day of cell seeding) the doubling time T of control MCF-7 cells was 1.15 days. T of cells treated with the peptide Int was 1.38 days, with an elongation of T of only 20% over controls. For cells treated with the peptide IntH1wt T was 1.64, with an elongation of T over controls of 43%. These results confirm the negligible (Int) or weak (Int-H1wt) activity already observed for these two peptides, at 10 µM concentrations, in our previous work (8) .
MCF-7 cells treated with Int-H1isoamph displayed a T of 2.22 days, with an elongation of T over controls of 93%. When MCF-7 cells were treated at the same 30 µM concentration with the L-peptide Int-H1-S6A,F8A, T became of 2.92 days, (an elongation of T over controls of 154%). These new experiments performed about three years after the first ones (8), on the same subline of MCF-7 cells (from cryopreserved vials), confirmed Int-H1-S6A,F8A as the most potent of our L-peptides in this cancer line. Cells treated with Int-H1-S6A,F8A also seem to be affected by a sort of delayed toxicity. Even if they are very far from saturation density, within two days (from day 8 to day 10) their number decreases from about 100,000 to only about 20,000 (equivalent to the initial number of cells seeded at day 0). A similar, but much milder, effect was observed with cells treated with Int-H1isoamph: during the last three days of growth the number of cells counted for the L-isoamphipatic modified peptide was always three to five times higher than in cells treated with Int-H1-S6A,F8A. The results of four independent experiments were homogeneous and highly significant (p < 0.002: according to a binomial distribution, one tailed). In fact, also the average counts from dishes that were completely independent from day to day (dishes related to counts at a given day could not affect counts at subsequent days because they were destroyed when cells were counted), showed that in no occasion, after the first treatment, a crossing over of cell numbers between samples treated with the two peptides could be observed, during the subsequent nine days. This event also is highly significant (p < 0.002 according to a binomial distribution, one tailed).
During the same interval (days 9 and 10), control cells and cells treated with the Int peptide seem to have reached a plateau of saturation density in a range between 800,000 and 1,100,000 cells per dish, approximately equivalent to 10 5 cells/cm 2 .
We have already reported that, during the last days of culture, in cells treated with Int-H1-S6A,F8A 10 µM, an important fraction of floating cells, largely apoptotic, could be observed, this observation was confirmed in the present experiments (data not reported) and could explain the delayed death of cells treated with Int-H1-S6A,F8A 30 µM (8).
The quantitative and statistical difference between the group of the three upper curves of Figure 3 and cell growth for cells treated with Int-H1-S6A,F8A 30 µM is more extreme. The difference between the slopes is always significant at a p < 10 -4 , one tailed. Int-H1isoamph is more active than Int-H1wt at a p < 0.02, than Int at a p < 0.002 and finally than control cells at a p < 10 -4 , one tailed (24).
Inhibition of growth by RI-peptides in the breast cancer line MCF-7
The growth curves of control MCF-7 cells and cells treated with our RI-peptides, are reported in Figure  3 (bottom graph). In Table 2 we give (also for our RI-peptides) the slopes of the different exponential curves, R 2 values of their regression lines, T (doubling time), and (T: % over controls) for the cell growth after treatment with RI-peptides.
We have explained in the introduction the reason for synthesizing our RI-peptides. If, for an interference between the quaternary structure of the Myc-Max heterodimer at the level of the four α-helix bundle, and surrounding proteins of the enhanceosome, an essential component of a transcription complex (25), our short peptides can assume inside the cell an α-helix conformation (a significant fraction of molecules per a significant fraction of time), than a RI-peptide can mimic the structure and the interactions of the original L-peptide.
We have seen, however, that RI-Int-H1-S6A,F8A is much more stable (resistant to the peptidases) than the corresponding L-peptide. We can therefore expect that RI-peptides may be more potent than corresponding L-peptides. This finding is indeed what we have observed. At a 5-µM concentration, RIInt and RI-Int-H1isoamph induce a 38% and a 23% elongation of T over controls, respectively; at the same 5-µM concentration RI-Int-H1-S6A,F8A can induce an elongation of T over controls of 231%. It is interesting to underline at least two points. The effect of RI-Int-H1-S6A,F8A seems to be very clearly sequence-specific (as already observed for the L-peptides), because the isoamphipathic RI-IntH1isoamph peptide is about ten times less active. In addition, RI-Int-H1-S6A,F8A 5 µM is clearly more active (231% elongation of T over controls) than the corresponding L-peptide Int-H1-S6A,F8A 30 µM (154% elongation of T over controls). From these results we can extrapolate that our RI-peptide is about ten times more active in MCF-7 cells than its corresponding L-peptide.
The results of Table 1 tend to show that RI-peptides have a half-life 30 to 35 times longer than Lpeptides, probably because they are almost completely resistant to peptidases. At the higher concentration studied, these very stable molecules display also additional types of toxic/antiproliferative effects independent of the presence of a sequence homologous of H1 of Myc. The effects observed in MCF-7 cells treated with our RI-peptides at a 10-µM concentration include features never observed in work with the corresponding L-peptides. Two days after the first treatment it was already more difficult to detach them from plastic with our standard tripsin buffer (10-min incubation at 25°C). During the subsequent days, for cells treated with RI-Int-H1-S6A,F8A and RI-Int-H1isoamph we needed a 15-min incubation at 37°C, but for RI-Int, cell detachment was difficult even after 40-min incubation at 37°C. This phenomenon was also associated with an alteration in gross cellular morphology never observed with L-peptides. Starting already three days after seeding, cells were less-well-spread on the plastic, small clusters formed that tended to loose contact with neighboring cells, cell contours became progressively more uneven. It is, however, remarkable that this peculiar type of side effect was impairing the growth of cells treated with RI-Int-H1isoamph 10 µM only mildly: 10 days after seeding, treated cells still had multiplied their number by approximately 20 times.
The dependence of these side effects on concentration was sharp. At 5 µM cell detachment was essentially normal and only very modest effects could be observed at the morphological level. Even if 10 µM seems to be a concentration already too high for RI-peptides, still the difference of behavior between RI-Int-H1-S6A,F8A and RI-Int-H1isoamph remains dramatic. The non-sequence-related effects of RI-Int-H1isoamph 10 µM are an elongation of T over controls of about 83%, but RI-Int-H1-S6A,F8A 10 µM abolishes almost completely the capability of growth of MCF-7 cells (T over controls = 479%). See also the bottom graph of Figure 3 .
During the last three days of cell growth, we counted cell numbers around 60,000 after treatment with RI-Int-H1-S6A,F8A 5µΜ. For the corresponding iso-amphipatic modified peptide cells are four or ten times more, at the respective concentrations of 10 or 5 µM. Cell number is 22 times higher for an equal 5-µM concentration of RI-Int. For all three comparisons, the difference in slope of the growth curves is not only qualitatively great but also statistically very significant. For RI-Int-H1-S6A,F8A 5 µM versus RI-Int 5 µM or versus RI-Int-H1isoamph 5 µM we have p < 5· 10 -5 , one tailed. The same extreme level of statistical significance is also achieved by comparing RI-Int-H1-S6A,F8A and RI-Int-H1isoamph at 10-µM concentrations. In addition, RI-Int-H1-S6A,F8A 5 µM is clearly more active even than RI-IntH1isoamph 10 µM; during the last three days of culture we count three to four times more cells, and, comparing the latter treatment with the first, this difference is statistically significant at a p < 0.002 (24) .
Inhibition of growth by L-peptides in the colon cancer line HCT-116
The growth curves of control HCT-116 cells and cells treated with our L-peptides, are reported in Figure 4 . In Table 3 we give the slopes of the different exponential growths, R 2 of the regression lines, T (doubling time), and (T: % over controls).
The colon cancer line HCT-116 is well capable of growth in the absence of serum. However, at lower cell densities (roughly below 50,000-70,000 cells/cm 2 in our experimental conditions) HCT-116 cells grow exponentially with a rapid doubling time T of about 17 h. Within a higher range of cell densities, (roughly 80,000-300,000 cells/cm 2 ) HCT-116 cells still continue to grow, but the average growth rate is much slower (T ∼ 52 h).
Because of the lack of serum, we expected a longer half-life for our L-peptides and more activity. We used therefore 10-µM concentrations. In the time interval between day 1 and 4 of rapid exponential growth, HCT-116 cells, that up to that time had experienced the effects of only a single treatment at day 1, were only slightly affected by our peptides. Int-H1-S6A,F8A and Int-H1isoamph induced a lengthening of T over controls of 32% and 52%, respectively (difference between the two statistically insignificant). Essentially no effects were observed with the other three peptides.
During the subsequent five days of slower growth, however, growth rates of cells treated with the Lpeptides H1-S6A,F8A (lacking the internalization sequence) or Int, were indistinguishable from controls, and Int-H1isoamph displayed only a mild effect (lengthening of T over controls = 59 %). In contrast with the behavior of the above L-peptides, Int-H1-S6A,F8A and Int-H1wt induced a regular steady decrease in cell counts going from day 4 to day 9 of culture. It is surprising that Int-H1wt displayed a delayed effect at least as strong as that of Int-H1-S6A,F8A. These two active peptides were capable of decreasing cell numbers from about 300,000 at day 4 to about 50,000 at day 9. That same day, cells treated with Int-H1isoamph were approximately 500,000 (10 times more). During the last six days the slope of growth curves of controls and of cells treated with Int or H1-S6A,F8A or IntH1isoamph, differed dramatically from the negative slope of a decline in cell numbers induced by Int-H1-S6A,F8A or Int-H1wt. The difference between positive and negative slopes (see Table 3 ) was extreme and always statistically significant at a p < 10 -4 , one tailed (24).
In the MCF-7 cells model [our previous results (8) and our new results presented in this paper] Int-H1wt had displayed a very weak activity. On the contrary, in the model of HCT-116 cells and the subsequent model of PBLs we are going to present, Int-H1wt (Int + the canonical H1 sequence of c-Myc) was clearly active, more or less with the same potency observed for Int-H1-S6A,F8A.
Inhibition of [ 3 H]-thymidine incorporation in PHA-stimulated peripheral blood lymphocytes after treatment with L-peptides
All the results related to PHA stimulated PBLs, treated with our L-peptides, are reported in Figure 5 (top graph). With the exception of the peptide H1-S6A,F8A (lacking the internalization sequence) all the other peptides showed a positive dose/response relationship. We considered biologically plausible that our type of phenomenon should be more linear (in the central part of the response-curve) as an f (log [concentration]) than as an f ([concentration]).
Therefore, we made a linear interpolation (equivalent to an average) of the results obtained at 10 and 30 µM, respectively, centered around the geometric mean (17.3 µM) of our two concentrations studied.
We obtained the following results, in terms of percentage of Thymidine incorporation versus controls (average ± SE):
Int:
99.8% ± 11.7 (from a total of 12 independent experiments); H1-S6A,F8A:
80.7% ± 6.1 (from a total of 9 independent experiments); Int-H1isoamph:
73.9% ± 13.0 (from a total of 21 independent experiments); Int-H1-S6A,F8A:
25.5% ± 5.1 (from a total of 9 independent experiments); Int-H1wt:
21.6% ± 6.0 (from a total of 7 independent experiments).
From our results we can draw the following conclusions. At the concentrations tested, Int seems to be almost inactive; as expected, the activity of H1-S6A,F8A (lacking the internalization sequence, and, as shown by Figure 2 , practically unable to enter the cell membrane of PBLs) is weak; it is also very weak the activity of Int-H1isoamph, where H1-S6A,F8A underwent an isoamphipathic modification (an indication of a significant degree of specificity of our active peptides bearing a correct H1 motif, even in this system of normal cells); finally Int-H1-S6A,F8A and Int-H1wt are clearly active and three to four times more active than the reference modified peptide described above.
Because we have performed a congruous number of independent experiments, the difference between the last two active peptides and the first three peptides is not only quantitatively important but also statistically very significant. Int-H1-S6A,F8A was more active than Int-H1isoamph at a p < 10 -4 , and more active than Int or H1-S6A,F8A at a p < 10 -5 . Int-H1wt was more active than Int-H1isoamph at a p < 10 -3 , and more active than Int or H1-S6A,F8A at a p < 10 -5 (26).
Inhibition of [ 3 H]-thymidine incorporation in PHA-stimulated peripheral blood lymphocytes after treatment with RI-peptides
The results related to PHA stimulated PBLs, treated with our RI-peptides, are reported in Figure 5 (bottom graph). At a concentration corresponding to the geometric mean between 5 and 10 µM, equivalent to 7.1 µM, we have obtained the following results, in terms of percentage of thymidine incorporation versus controls (average ± SE):
60.6% ± 2.8 (from a total of 6 independent experiments); RI-Int-H1isoamph:
61.7% ± 10.0 (from a total of 6 independent experiments); RI-Int-H1-S6A,F8A:
21.3% ± 4.7 (from a total of 12 independent experiments).
The RI-Int peptide already displays some toxicity. The fraction of thymidine incorporation in respect to controls is approximately 60%. In contrast the corresponding L-peptide Int is essentially inactive at 17.3 µM (a concentration 2.5 times higher). PBLs treated with RI-peptides become also apparently more rounded or smaller in size. This toxicity of RI-Int is obviously completely independent of an H1-Myc related amino-acidic sequence and is reminiscent of what we have described for the same peptide in the MCF-7 cells model. The very long half-life of the D-peptides in respect to the L-peptides could obviously play a role (see Table 1 ).
A similar consideration can be made also for RI-Int-H1isoamph. The presence of an active H1-Myc type sequence in an RI-peptide is however clearly relevant also in this cellular system. At 7.1 µM the percentage of thymidine incorporation is approximately 20% for RI-Int-H1-S6A,F8A. The inhibitory effect is about three times stronger than the one observed with RI-Int-H1isoamph or RI-Int. In addition, at 10 µM, while for RI-Int and RI-Int-H1isoamph we have observed only a partial inhibition around 40%-50%, RI-Int-H1-S6A,F8A is capable of a complete 100% inhibition of thymidine incorporation. As expected from literature data (27) , the positive control of an appropriate myc-antisense, in a concentration range 5-30 µM, was inhibiting thymidine incorporation by 80%-90%.
Because we have performed a congruous number of independent experiments, the difference between the active peptide and the other two peptides is not only quantitatively important but also statistically very significant. RI-Int-H1-S6A,F8A was more active than RI-Int at a p < 10 -5 , and more active than RIInt-H1isoamph at a p < 10 -3 (26) .
Transcription levels of ODC, p53 and GAPDH genes, as evaluated by RT-PCR analysis
A semi-quantitative RT-PCR (as described in Methods) was performed on RNA extracted from PHA stimulated PBLs, treated with different peptides. Two bona fide c-Myc target genes, namely ODC and p53, were assayed in comparison with the housekeeper gene GAPDH, which, however, is not insensitive to stimulation of cell division (see the bottom of Table 4 ).
In each experiment, for each type of amplified c-DNA, two reference controls were always present: quiescent PBLs and PHA-stimulated PBLs. Examining the absolute values in Arbitrary Units (A.U.) we found that each band intensity, for control and stimulated PBLs, displayed a distribution close to normality with the means ± SE that are indicated at the bottom of Table 4 .
It seems important to underline that, in PBLs not stimulated with PHA, but perhaps partially stimulated from the culture conditions, mRNA levels of the three genes were already significant, at least 50% in comparison with PHA stimulated PBLs. These differential changes in mRNA levels take place in a more general context in which the global amount of mRNA approximately doubles going from nonstimulated to stimulated PBLs. GAPDH is probably rather independent of c-Myc, but is required for the fragmentation of an exose in two triose moieties, followed by downstream oxidation and ATP production. We would expect an activation of this pathway in cells going to divide (28) .
In each gel, for each amplified c-DNA, the two controls mentioned above were always present, together with different types of treated samples. Each band intensity of amplified c-DNA coming from a treated sample was always referred to its corresponding internal control of PHA-stimulated PBLs. This internal standard was made equal to a 100% of response, by definition.
As shown in Table 4 , both ODC and p53 respond mainly to our active L-peptides, Int-H1-S6A,F8A and Int-H1wt, more weakly to Int-H1isoamph, and just slightly to the control L-peptides Int (lacking any kind of H1 related sequence) and H1-S6A,F8A (lacking an internalization sequence). As expected, considering their lower concentration, RI-peptides appear more potent than the corresponding Lpeptides. Again, RI-Int-H1-S6A,F8A is more active than its corresponding iso-amphipatic modified peptide.
The target gene p53 tends to be regularly more sensitive to inhibition than ODC. It is worthy to note that the inhibition obtained with our active peptides brings ODC at the levels observed in un-stimulated lymphocytes and p53 even below these levels. It is also interesting to observe that GAPDH, even if not insensitive to PHA stimulation and in general to a commitment to cell division (29), seems to play its role in a part of the signal network completely unaffected by our peptides, and probably far from genes more directly controlled by the c-Myc family.
In the last column of Table 4 we summarize our results: The number of dots reflects an average of the combined effects of each peptide on the studied target genes ODC and p53, in terms of global strength of the inhibition of expression. We have correlated the effects of our peptides on thymidine incorporation and on mRNA levels by using a rank correlation approach. We have used the Spearman's Rho test (30) . For PBLs treated with the same concentrations of our peptides, ODC mRNA levels and thymidine incorporation are positively correlated with p ~ 0.002. p53 mRNA levels and thymidine incorporation are positively correlated with p ~ 0.021.
DISCUSSION
The most important results of this manuscript can be summarized as follows. We have confirmed that the third α-helix of Antennapedia is capable of delivering our peptides inside different types of cells: a mammary cancer line, a colon cancer line and also normal peripheral blood lymphocytes stimulated with PHA. This seems to be true not only for our L-peptides, but apparently also for our RI-peptides, at least judging from their biological behavior. The group of Derossi and Prochiantz (31) has shown that indeed also variants of the Int sequence containing D-amino acids are able to cross the cytoplasmic membrane. They did not report that also an RI-Int sequence is able to cross the cytoplasmic membrane: Our finding is indeed increasing the spectrum of possible basic amino acidic sequences capable of transporting into the cell up to the nucleus a peptidic/peptidomimetic motif.
We have synthesized the corresponding RI-peptides of some of the most relevant of our L-peptides. The half life of our RI-peptides is about 30-35 times longer than the half life of our L-peptides because they are much more resistant to the peptidases.
We have confirmed that peptides containing only the Antennapedia sequence (Int) or a sequence homologous of H1 of Myc, but not carrying the internalization sequence Int are largely inactive. The peculiar toxic effects of RI-Int 10 µM on MCF-7 cells, and the milder effects observed on PBLs seem totally unrelated to the effects mediated trough the H1 motif of c-Myc.
It was important to investigate in three different biological systems, if a sequence with > 50% proximity to H1 of c-Myc (both in its L-and RI-forms), could be systematically and clearly less active than the H1-S6A,F8A or H1wt sequences. We chose an iso-amphipatic modified sequence in which hydrophobic amino acids had been replaced with hydrophobic amino acids from the same sequence, Asp only with Glu or vice versa, the same for Asn and Gln, for Lys and Arg, leaving invariant the Arg at position 11, one of the most conserved residues of the Myc/Max family proteins. We have analyzed in details the specific differences of this motif from the H1 of Myc motifs and other related sequences in the "Results" section. Our H1isoamph was probably a good control of selectivity of the observed effects. The clear cut difference of activity constantly observed in comparison with the active peptides (both for L-and RI-forms), opens the possibility of testing sequences even closer to H1-S6A,F8A or H1wt.
In MCF-7 cells, after completing treatments at days 1, 4 and 7, during the last three days of growth the number of cells counted for the L-iso-amphipatic modified peptide was always three-five times higher than in cells treated with Int-H1-S6A,F8A. This difference was qualitatively relevant and was also statistically very significant. In addition, a crossing over of cell numbers between the two peptides was never observed (Fig. 3) . This difference is also statistically highly significant. As expected and already observed (8) the Int sequence from Antennapedia was practically inactive. We have also confirmed (8) that in the model of MCF-7 cells, Int-H1wt displays a very weak activity. This is at difference with what we have observed in the other two cellular systems studied. The reason of this difference is obscure to us.
Things were even more clear-cut when MCF-7 cells were tested with our RI-peptides. For instance, while RI-Int-H1isoamph 5 µM would increase the doubling time of only 23%, the same concentration of RI-Int-H1-S6A,F8A increased the doubling time of 231% (10 times more!). RI-Int-H1isoamph 10 µM increased the doubling time of MCF-7 cells by 83%, suggesting the presence of some toxic side-effect, but the same concentration of RI-Int-H1-S6A,F8A was increasing the doubling time of 479% (6 times more!). RI-Int 5 µM was also six times less active than RI-Int-H1-S6A,F8A given at the same concentration. For all the three comparisons described above the statistical significance of the differences was extreme (p < 5· 10 -5 ).
RI-Int (only at 10 µM) displayed unexpected side-effects. Around day 7 (third treatment) it became impossible to detach MCF-7 cells from plastic with the usual concentration of trypsin, cell morphology was also altered, as already described in the "Results" section. This unexpected behavior of especially RI-Int at the highest concentration, is not obscuring the dramatic overall differential in activity observed between RI-Int-H1-S6A,F8A and the other two peptides not carrying or carrying an inadequate H1 motif.
The relevance of the presence of a Myc H1 motif in inhibiting growth of MCF-7 cells was completely confirmed in the colon cancer line HCT-116. This cancer line is capable of growth without serum and is over-expressing c-Myc (O'Connor P.M., personal communication), probably as a consequence of an inactivation of both alleles of the APC recessive oncogene (32) . The lack of serum peptidases makes this line more sensitive to our L-peptides.
After the second treatment, at day four, the behavior of the two active peptides containing the Myc H1 motif became completely different from the behavior of Int-H1isoamph. We observed a steady decline in cell numbers for the two active peptides, in contrast with a substantial regular growth for the IntH1isoamph peptide. The behavior of cells treated with Int or H1-S6A,F8A was practically indistinguishable from controls. In this cell line changes from S6 to A and from F8 to A in the H1 motif, that Draeger and Mullen had claimed to increase helicity (14) , was apparently irrelevant for activity.
We wanted to investigate the activity of our peptides also in a system of normal human cells that is well known to display a peak of c-Myc activity after PHA stimulation and is sensitive to c-myc mRNA inhibition by antisense phosphorothioates, followed by a downstream inhibition of 3H-thymidine incorporation (33) .
The crucial comparison was again between the active Int-H1-S6A,F8A, Int-H1wt or RI-Int-H1-S6A,F8A , and their corresponding counterparts in which the H1-S6A,F8A motif had been subjected to iso-amphipathic aa substitutions, as described in the Results section.
Inhibition of 3H-thymidine incorporation by the peptides capable of internalization and containing the cMyc H1 motif (including the L-peptide Int-H1wt) was always three times stronger than inhibition by their iso-amphipatic modified counterparts. The differences were always important and the results obtained well reproducible from experiment to experiment, as indicated from the SE around the means; as a consequence, the statistical significance of the differences involved was always very strong (p < 10 -3 or even p < 10 -4 ), as reported in the "Results" Section. In the case of the peptides Int or H1-S6A,F8A or RI-Int, the difference with the three active peptides was even more extreme (p < 10 -5 ). Even in this model of normal human cells the two L-peptides Int-H1-S6A,F8A and Int-H1wt were equally active, in contrast with the weak activity of Int-H1wt observed in MCF-7 cells.
The inhibitory activity of our peptides toward normal lymphocytes stimulated to proliferate deserves an ad hoc comment. Perturbation of functions within the Myc/Max family can affect not only cancer cells, but also normal cells, a phenomenon that was even expected for us, because an overexpressed/disregulated oncogene protein in a cancer cell is first of all an essential signaling protein in an appropriate normal cell at the right moment. Possible drugs derived from our lead molecules could even be of interest as immunodepressive agents.
The possibility of finding molecules derived from our leads, endowed with relevant therapeutic indexes against cancers affected by excess of Myc function, is something that we shall start to explore soon in vivo, starting from RI-Int-H1-S6A,F8A.
At the theoretical level, we were well aware of the fact that genes assumed to be under the transcriptional control of the gene product (protein) of another gene, are probably modulated in their expression (and at other levels) by a multiplicity of proteins, in some sort of regulatory network, as suggested by attempts to build relational data bases of protein cross-talks, referring in our case to a network subset involved mainly in control of cell proliferation (34 and Kohn K.W. personal communication). As a consequence, it was not straightforward to predict what was going to happen, touching a system of such a complexity, even if our 'touch' was hopefully relatively selective.
At the technical level, as we have explained in the Materials and Methods and Results sections, we have been careful in trying to control all the parameters involved in our RT-PCR based experiments, that could confer a reasonable quantitative significance to our results, at least in relative terms, well aware of the unavoidable noise affecting this type of measure.
Considering the two different types of difficulties mentioned above, it was very comforting to notice that 3H-thimidine incorporation and mRNA levels are reasonably well correlated, especially for ODC (p ~ .002), but also for p53 (p ~ .021), whereas, on the contrary, GAPDH is essentially unaffected, even if this last gene is probably useful for burning the exoses and supplying energy to dividing cells (26, 35) .
In conclusion, the peptides carrying an iso-amphipatic modified H1 sequence, were always very clearly or even dramatically less active than the corresponding peptides carrying a conserved "H1 of Myc" motif. This happened in five different independent situations (all the cellular models considered at the present time): It is difficult not to consider seriously the possibility that the effects that we have observed and reported in the present work, together with our previous results (8) , suggest that indeed the antiproliferative activities that we have registered are related to the presence in our active molecules of a specific Myc motif. The molecular interference is most probably taking place at the interior of the boundary of the set of related molecules that we can refer to the Myc/Max family (36), and we would expect that this happens at the level of the common domain present in these homo/hetero-dimers: the four α-helix bundle, because H1 of Myc belongs to this domain. We could have a direct disturbance in the formation of the bundle, but we could have as well an interference at the level of the enhanceosome (25) , at the interface between the bundle and surrounding proteins of the higher order structure. As a matter of fact, if these protein-protein interactions with the outside of the bundle were less strong than the cooperative forces keeping the heterodimer together, they could be even more sensitive to an excess of competing presence of our peptides.
According to Prochiantz (37) , basic side chains of amino acids can bind negatively charged atoms/hydrogen bonds acceptors of membrane phospholipids, gangliosides, glycosaminoglycans, polysialic acids. After binding to the external side of the membrane, they have hypothesized a model of cargo internalization, where a basic peptide and his cargo never leaves the aqueous environment. After invagination, the hydrophilic pocket of a reverse micelle can stochastically move toward and reopen at the internal side. In addition to homeoproteins like Antennapedia, the transcription-activating factor Tat of HIV, and Herpes VP22 protein can cross cytoplasmic membranes with receptor-independent similar mechanisms (22, 38, 39) . Recently, S. R. Schwarze et al. have shown that a sequence of 11 mostly basic amino acids from Tat can internalize efficiently proteins around 120 kDa (∼ 10 3 aa) not only inside cells grown in vitro, but also inside cells of mouse tissues in vivo (40) . It comes natural the suggestion of investigating common structural traits (both natural and modified/peptidomimetic sequences) at the basis of these internalization phenomena, in the perspective of opening new pharmacological avenues.
The possibility of using the reverse micelle generated by Int or RI-Int as a general purpose container, has made possible the strategy that is perhaps the most innovative aspect of this paper, behind the specific interest for the specific inhibition of functions related to the c-Myc protein (an important dominant oncogene).
With our work, we propose a general strategy of pharmacological attack of intracellular protein functions not through a small (for instance around 500 daltons) and compact drug-like molecule but through a larger structure (in the order of 3500 daltons in this case, but we have started to move in the direction of doubling the size of our peptidomimetic molecules). In fact, we have just synthesized and started to study peptidomimetic molecules containing the [H1-Loop-H2 motif] of c-Myc.
If it becomes systematically possible to use a retro-inverso conformation of Int (or the like) to introduce interacting motifs at least five-ten times more extended in terms of interaction surface space than the usual size of a typical 'drug-like molecule', we can hope to achieve a broader vision of the target. In addition, structural motifs used by natural signaling proteins for their cross-talks can become an useful inspiration, especially if RI-α-helices resistant to the peptidases (and other peptidase resistant peptidomimetic motifs) can already be used as a starting point for searching further improvements in terms of affinity and selectivity. It could be useful to have a molecule able to 'see' at least (25-50 Å) 2 of the surface of a target protein, instead of the usual (5-10 Å) 2 'seen' by a typical more compact and smaller drug-like molecule.
Perhaps it could be a limit for several varieties of combinatorial chemistry approaches to generate libraries of compact drug-like molecules endowed with an enormous diversity of multiple interactors, both in terms of combinations, space distribution and orientation, but in too limited a space. We could advance the consideration that the typical informational content of signaling proteins is extremely high, but often more diluted in space than the informational content of drug-like molecules. We are curious about the potential of combinatorial libraries not starting from scratch, but implanted over the scaffold of a lead peptidomimetic motif suggested by nature (41). For each batch, degradation rate per hour (± SE), half-life (a) , and the R 2 of a regression line through the origin of the equation ln Q t /Q 0 =-kt (b) are given. In the last column, a degradation rate ratio between the L-and Ri-peptides is given. Table 2   Table 2 . Parameters derived from a regression analysis performed on growth curves of MCF-7 cells (see target genes ODC and p53 were assayed in comparison with the housekeeper gene GAPDH. For each treatment, the expression level (Mean ± SE) in respect to PHA-stimulated untreated cells is indicated (for details see text). In brackets is the number of repeated experiments. In the last column, the number of black dots reflects an average intensity of expression inhibition (effect on ODC and p53 combined). Lower panel: band intensity in Arbitrary Units (Mean ± SE) of non-stimulated and PHA-stimulated PBLs. In brackets is the number of repeated experiments. . Cells were treated with peptides at days 1, 4, and 7. Each single point/day was determined as an average of fourto-six independent hemocytometer counts and the tripan blue dye exclusion test. Experiments were repeated twice in duplicate for L-peptides, and three times (always in duplicate) for RI-peptides. 
